Sign Out
Hepabig should be administered very carefully to patients with IgA deficiency syndrome.
Hepabig should be administered intramuscularly only and not intravenously.
In neonates who are administered one dose of 1 ml, Hepabig is injected at two different sites (0.5 ml/site).
Do not reuse or save for future use. This product contains no preservative; therefore, partially used vials should be discarded immediately.
Continue with Google